0001012975-20-000511.txt : 20200529 0001012975-20-000511.hdr.sgml : 20200529 20200529170446 ACCESSION NUMBER: 0001012975-20-000511 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 EFFECTIVENESS DATE: 20200529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst Capital II, L.P. CENTRAL INDEX KEY: 0001777452 IRS NUMBER: 841769755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-340653 FILM NUMBER: 20929071 BUSINESS ADDRESS: STREET 1: 515 MADISON AVENUE, SUITE 2701 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-752-2226 MAIL ADDRESS: STREET 1: 515 MADISON AVENUE, SUITE 2701 CITY: NEW YORK STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0001777452 Health Catalyst Capital II, L.P. 515 MADISON AVENUE, SUITE 2701 NEW YORK NY NEW YORK 10022 212-752-2226 DELAWARE None None Limited Partnership true 2019 N/A Health Catalyst Associates II, LLC 515 Madison Avenue Suite 2701 New York NY NEW YORK 10022 Director General Partner of the Issuer. Charles Boorady 515 Madison Avenue Suite 2701 New York NY NEW YORK 10022 Executive Officer Daniel Ross 515 Madison Avenue Suite 2701 New York NY NEW YORK 10022 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 3C.7 true 0001777452-19-000001 2019-06-25 true true false 50000 DeepWave Partners LLC None None None Office 10, Level 1, Sharjah Media City PO Box 515000 Sharjah C0 UNITED ARAB EMIRATES 000000 true 275000000 50752500 224247500 Total Offering Amount and Total Amount Sold are inclusive of the General Partner's commitment. false 12 0 true 0 true 0 true A fee for management services calculated quarterly and based on a percentage of commitments will be paid to an affiliate of the Issuer. false Health Catalyst Capital II, L.P. /s/ Charles Boorady Charles Boorady Founding Managing Director 2020-05-29